<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Ophthalmol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Ophthalmology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Ophthalmol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2674-0826</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fopht.2025.1612964</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Case Report: Rapid cataract development preceding diabetes mellitus in <italic>WFS1</italic> spectrum disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Gulani</surname><given-names>Aaishwariya A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Duggan</surname><given-names>Courtney</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Ledoux</surname><given-names>Danielle M.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name><surname>Gaier</surname><given-names>Eric D.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1343024/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Hamilton Eye Institute University of Tennessee</institution>, <city>Memphis</city>, <state>TN</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff2"><label>2</label><institution>Massachusetts Eye and Ear</institution>, <city>Boston</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff3"><label>3</label><institution>Specialized Pediatric Eye Care</institution>, <city>Beverly</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Ophthalmology, Boston Children&#x2019;s Hospital</institution>, <city>Boston</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Ophthalmology, Harvard Medical School</institution>, <city>Boston</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<aff id="aff6"><label>6</label><institution>Picower Institute for Learning and Memory, Massachusetts Institute of Technology</institution>, <city>Cambridge</city>, <state>MA</state>,&#xa0;<country country="us">United States</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Eric D. Gaier, <email xlink:href="mailto:eric.gaier@childrens.harvard.edu">eric.gaier@childrens.harvard.edu</email></corresp>
<fn fn-type="equal" id="fn003">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-09-09">
<day>09</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>5</volume>
<elocation-id>1612964</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>08</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Gulani, Duggan, Ledoux and Gaier.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Gulani, Duggan, Ledoux and Gaier</copyright-holder>
<license>
<ali:license_ref start_date="2025-09-09">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><italic>WFS1</italic> spectrum disorder is a rare condition, characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD). A 2-year-old female patient with a history of sensorineural hearing loss presented with rapid, sequential cataract development. Diabetes mellitus was not manifested at the time but developed 4 years later. While cataracts have been described in this syndrome, rapid acquisition of cataracts in the setting of mild hyperglycemia was unique considering they could not be definitively attributed to diabetes mellitus alone. This case provides real-world evidence that rapid <italic>WFS1</italic>-related cataract development may result from the underlying condition in conjunction with or independent from <italic>WFS1</italic>-associated diabetes mellitus.</p>
</abstract>
<kwd-group>
<kwd>WFS1 spectrum disorder</kwd>
<kwd>Wolfram syndrome</kwd>
<kwd>cataract</kwd>
<kwd>diabetes mellitus</kwd>
<kwd>optic atrophy</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Eye Institute</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100000053</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">
<institution-wrap>
<institution>Boston Children's Hospital</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100006823</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by NIH K08 EY030164 (EDG).</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="12"/>
<page-count count="4"/>
<word-count count="1174"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Neuro-Ophthalmology Disorders</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p><italic>WFS1</italic> spectrum disorder (<italic>WFS1</italic>-SD) is a rare genetic condition, characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD) (<xref ref-type="bibr" rid="B1">1</xref>). Patients typically present with insulin-dependent diabetes mellitus at a median age of 6 years and optic atrophy at 11 years (<xref ref-type="bibr" rid="B1">1</xref>). Other manifestations include neurological deficits, primarily ataxia, anterior pituitary dysfunction, and urological complications such as hydroureteronephrosis; most of these present later in life and, thus, are screened for once the genetic diagnosis is made (<xref ref-type="bibr" rid="B2">2</xref>). Aside from optic atrophy, ophthalmic manifestations include cataracts, pigmentary retinopathy, and diabetic retinopathy (<xref ref-type="bibr" rid="B2">2</xref>). This case provides evidence that rapid <italic>WFS1</italic>-related cataract development may result from the underlying condition perhaps in conjunction with <italic>WFS1</italic>-associated diabetes mellitus.</p>
<p>A 2-year-old female patient was transferred from an outside emergency department because of right eye leukocoria and exotropia. Two weeks prior to presentation, the patient&#x2019;s mother noticed the patient closing the right eye, which was drifting out more with a &#x201c;cloudy haze&#x201d; over the pupil. Examination on presentation revealed visual acuities of light perception OD and 20/160 (Teller) OS. She manifested a constant exotropia and left eye fixation preference (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>). A complete cataract precluded any view to the right fundus. B-scan ultrasound was without retinal detachment. There was optic disc pallor on the left with no significant cataract precluding an adequate view to the fundus.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>External photographs of exotropia and cataracts. <bold>(A)</bold> Day 0&#x2014;first exam/presentation. <bold>(B)</bold> Day 5&#x2014;under anesthesia just prior to cataract extraction on the right.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fopht-05-1612964-g001.tif">
<alt-text content-type="machine-generated">Child's eyes in two images marked A and B. Image A shows both eyes with a right exotropia, mydriasis and cataract, and the left eye fixating on the camera with no cataract. Image B shows both eyes after application of fluorescein and dilating drops showing exotropia of and cataracts in both eyes.</alt-text>
</graphic>
</fig>
<p>The patient had been born at term via c-section with APGAR scores of 8 and 9. She had a failed auditory screening at birth that prompted further workup. Infectious screening, including cytomegalovirus and rubella, was negative. Magnetic resonance imaging (MRI) pursued as a part of this workup showed bilateral hypoplastic auditory nerves and no comment on the optic nerves. In addition to congenital hearing loss, she had a malpositioned anus, poor weight gain, and short stature and was referred to genetics for further workup. Workup showed high concentrations of amino acids and hyperammonemia, three auricular tags, and normal eyes with reactive pupils. At age 1, an ophthalmologist diagnosed intermittent exotropia; no other ocular abnormalities were reported. She did not have a relative afferent pupillary defect. Family history was significant for insulin-dependent diabetes mellitus in her mother, uncle, and maternal grandfather. Genetic testing of the patient revealed a heterozygous missense variant of likely risk [NM_006005.3(WFS1):c.2430C&gt;G (p.Phe810Leu); rs1553879021] in <italic>WFS1</italic> (Otogenome, Laboratory for Molecular Medicine). This variant is listed in ClinVar (<xref ref-type="bibr" rid="B3">3</xref>) and absent from gnomAD (<xref ref-type="bibr" rid="B4">4</xref>), but a variant with the same translational consequence was recently reported as likely pathogenic (<xref ref-type="bibr" rid="B5">5</xref>). Multiple <italic>in silico</italic> analyses of the variant were suggestive of pathogenicity. The patient&#x2019;s mother did not carry the variant, and the father, whose family history is unknown, was not available for testing.</p>
<p>The decision was made to remove the cataract. The right eye cataract extraction with intraocular lens (IOL) placement occurred 5 days after initial presentation to the emergency department. Dilated fundus examination under anesthesia after cataract removal revealed a pale right optic disc. During this exam, it was apparent that the left lens had become involved with a smaller, central cataract (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>). She underwent left cataract extraction with IOL placement 5 weeks later. There was no posterior bulge to either lens to suggest persistent fetal vasculature or posterior lentiglobus. </p>
<p>One-month post-operative assessment confirmed bilateral pallor with a cup-to-disc ratio of 0.8 OD and 0.4 OS. Visual acuities had improved to 20/130 OD and OS, and she was prescribed bifocal glasses to optimize her visual development. Hemoglobin A1c was 6.1%, 5.9%, and 6.5% at 1, 3, and 4 months post-operatively, respectively, with home fasting finger-stick glucose values of 78&#x2013;90 mg/dL without treatment. Serum osmolality at that time was normal (286 mOsm/kg). Six months post-operatively, the patient began experiencing polyuria and polydipsia and her hemoglobin A1c was found to be 7.2%. She was referred to a local hospital for admission and initiation of insulin therapy. Three years later, visual acuity with correction was 20/41 with both eyes viewing (Teller; patient would not tolerate monocular occlusion).</p>
<p>Early life cataracts have primarily been associated with dominant <italic>WFS1</italic>-SD (<xref ref-type="bibr" rid="B1">1</xref>). Berry et&#xa0;al. isolated a missense mutation in <italic>WFS1</italic> (distinct from our patient&#x2019;s; c.1385A-to-G in exon 8, E462G) that causes congenital nuclear cataracts (<xref ref-type="bibr" rid="B6">6</xref>). De Franco et&#xa0;al. described spontaneous heterozygous <italic>WFS1</italic> variants associated with neonatal diabetes, deafness, and congenital cataracts within the first year of life, a more severe phenotype than typical of <italic>WFS1</italic>-SD (<xref ref-type="bibr" rid="B7">7</xref>). Our patient already carried a diagnosis of <italic>WFS1</italic>-SD after genetic testing triggered by identification of sensorineural hearing loss and reportedly had a complete screening eye examination without cataracts. She subsequently developed rapid-onset, sequential cataracts in the setting of prediabetic glycemic screening. Similarly, a recent report describes a Pakistani child who acquired cataracts at age 3, subsequently developed systemic manifestations of diabetes mellitus 2 years later, and harbored a different, novel, heterozygous <italic>WFS1</italic> variant (<xref ref-type="bibr" rid="B8">8</xref>). While we cannot exclude the fact that our patient had subtle congenital cataracts that progressed, her normal dilated ophthalmic examination prior to presentation suggests they were acquired.</p>
<p>Outside of <italic>WFS1</italic>-SD, rapid cataract development can be seen in isolated diabetes mellitus, albeit in &lt;1% of cases. However, among pediatric patients who develop diabetes-related cataracts, hyperglycemic severity ranges well beyond those seen in this patient with HbA1c percentages of 9.0% (8.55%&#x2013;9.38%, <italic>p</italic> &lt; 0.001) in patients with early cataracts (<xref ref-type="bibr" rid="B9">9</xref>). The wolframin protein is expressed in the developing lens (<xref ref-type="bibr" rid="B6">6</xref>), and it plays various roles in the regulation of endoplasmic reticulum stress and calcium homeostasis (<xref ref-type="bibr" rid="B10">10</xref>). These same cellular functions are implicated in the cataract development in diabetes mellitus (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Taken together, we posit that increased baseline endoplasmic reticulum stress secondary to compromised wolframin function may impart increased susceptibility to hyperglycemic stress in lens cells to yield early and rapid cataract development in the setting of relatively mild glycemic dysregulation. Runaway, vicious-cycle mechanisms may explain the sequential nature of rapid development seen in this case.</p>
<p>The chronology of cataracts presenting prior to the diagnosis of insulin-dependent diabetes along with the <italic>WFS1</italic> variant noted in our patient is unique but aligns with prior studies that identify <italic>WFS1</italic> gene dysfunction as a pathway for cataract formation converging with those related to diabetes mellitus. This case suggests that rapidly acquired cataract formation can result from dominant <italic>WFS1</italic>-SD and should be worked up with genetic testing in certain clinical contexts.</p>
</body>
<back>
<sec id="s1" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s2" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s), and minor(s)&#x2019; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s3" sec-type="author-contributions">
<title>Author contributions</title>
<p>AG: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. CD: Writing &#x2013; review &amp; editing, Data curation. DL: Supervision, Writing &#x2013; review &amp; editing, Data curation. EG: Funding acquisition, Project administration, Supervision, Data curation, Investigation, Conceptualization, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s5" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>EG: Luminopia, Inc. advisor, equity, patent; Stoke Therapeutics, Inc. consultant; Neurofieldz, Inc. consultant.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s6" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s7" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barrett</surname> <given-names>TG</given-names></name>
<name><surname>Bundey</surname> <given-names>SE</given-names></name>
</person-group>. 
<article-title>Wolfram (DIDMOAD) syndrome</article-title>. <source>J Med Genet</source>. (<year>1997</year>) <volume>34</volume>:<page-range>838&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jmg.34.10.838</pub-id>, PMID: <pub-id pub-id-type="pmid">9350817</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rigoli</surname> <given-names>L</given-names></name>
<name><surname>Bramanti</surname> <given-names>P</given-names></name>
<name><surname>Di Bella</surname> <given-names>C</given-names></name>
<name><surname>De Luca</surname> <given-names>F</given-names></name>
</person-group>. 
<article-title>Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease</article-title>. <source>Pediatr Res</source>. (<year>2018</year>) <volume>83</volume>:<page-range>921&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/pr.2018.17</pub-id>, PMID: <pub-id pub-id-type="pmid">29774890</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><collab>ClinVar</collab>
</person-group>. Available online at: <uri xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/RCV003128249/">https://www.ncbi.nlm.nih.gov/clinvar/RCV003128249/</uri>.
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><collab>gnomAD browser</collab>
</person-group>. Available online at: <uri xlink:href="https://gnomad.broadinstitute.org/gene/ENSG00000109501?dataset=gnomad_r4">https://gnomad.broadinstitute.org/gene/ENSG00000109501?dataset=gnomad_r4</uri> (Accessed <date-in-citation content-type="access-date">August 8, 2025</date-in-citation>).
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>de Muijnck</surname> <given-names>C</given-names></name>
<name><surname>Haer-Wigman</surname> <given-names>L</given-names></name>
<name><surname>van Everdingen</surname> <given-names>JAM</given-names></name>
<name><surname>Lushchyk</surname> <given-names>T</given-names></name>
<name><surname>Heutinck</surname> <given-names>PaT</given-names></name>
<name><surname>Van Dooren</surname> <given-names>MF</given-names></name>
<etal/>
</person-group>. 
<article-title>Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy</article-title>. <source>Sci Rep</source>. (<year>2024</year>) <volume>14</volume>:<fpage>22956</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-024-74364-x</pub-id>, PMID: <pub-id pub-id-type="pmid">39363032</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Berry</surname> <given-names>V</given-names></name>
<name><surname>Gregory-Evans</surname> <given-names>C</given-names></name>
<name><surname>Emmett</surname> <given-names>W</given-names></name>
<name><surname>Waseem</surname> <given-names>N</given-names></name>
<name><surname>Raby</surname> <given-names>J</given-names></name>
<name><surname>Prescott</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>Wolfram gene (WFS1) mutation causes autosomal dominant congenital nuclear cataract in humans</article-title>. <source>Eur J Hum Genet</source>. (<year>2013</year>) <volume>21</volume>:<page-range>1356&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ejhg.2013.52</pub-id>, PMID: <pub-id pub-id-type="pmid">23531866</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Franco</surname> <given-names>E</given-names></name>
<name><surname>Flanagan</surname> <given-names>SE</given-names></name>
<name><surname>Yagi</surname> <given-names>T</given-names></name>
<name><surname>Abreu</surname> <given-names>D</given-names></name>
<name><surname>Mahadevan</surname> <given-names>J</given-names></name>
<name><surname>Johnson</surname> <given-names>MB</given-names></name>
<etal/>
</person-group>. 
<article-title>Dominant ER stress-inducing WFS1 mutations underlie a genetic syndrome of neonatal/infancy-onset diabetes, congenital sensorineural deafness, and congenital cataracts</article-title>. <source>Diabetes</source>. (<year>2017</year>) <volume>66</volume>:<page-range>2044&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db16-1296</pub-id>, PMID: <pub-id pub-id-type="pmid">28468959</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hanif</surname> <given-names>MI</given-names></name>
<name><surname>Ahmed</surname> <given-names>H</given-names></name>
<name><surname>Ibrahim</surname> <given-names>MN</given-names></name>
<name><surname>Raza</surname> <given-names>SJ</given-names></name>
<name><surname>Ahmed</surname> <given-names>SA</given-names></name>
</person-group>. 
<article-title>A novel <italic>de novo</italic> likely pathogenic variant of wfs-1 gene in a Pakistani child with non-classic wfs-1 spectrum disorder</article-title>. <source>J Ayub Med Coll Abbottabad</source>. (<year>2024</year>) <volume>36</volume>:<page-range>433&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.55519/JAMC-02-12379</pub-id>, PMID: <pub-id pub-id-type="pmid">39609996</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Reiter</surname> <given-names>UM</given-names></name>
<name><surname>Eckert</surname> <given-names>AJ</given-names></name>
<name><surname>Dunstheimer</surname> <given-names>D</given-names></name>
<name><surname>Bechtold-Dalla Pozza</surname> <given-names>S</given-names></name>
<name><surname>Lullwitz</surname> <given-names>C</given-names></name>
<name><surname>Golembowski</surname> <given-names>S</given-names></name>
<etal/>
</person-group>. 
<article-title>Cataract in children and adolescents with type 1 diabetes. Insights from the German/Austrian DPV registry</article-title>. <source>Pediatr Diabetes</source>. (<year>2022</year>) <volume>23</volume>:<page-range>362&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/pedi.13316</pub-id>, PMID: <pub-id pub-id-type="pmid">35064955</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rigoli</surname> <given-names>L</given-names></name>
<name><surname>Lombardo</surname> <given-names>F</given-names></name>
<name><surname>Di Bella</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Wolfram syndrome and WFS1 gene</article-title>. <source>Clin Genet</source>. (<year>2011</year>) <volume>79</volume>:<page-range>103&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01522.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20738327</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>H</given-names></name>
<name><surname>Yang</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Endoplasmic reticulum stress as a regulator of high glucose-induced epithelial-mesenchymal transition in human lens epithelial cells</article-title>. <source>J Ocul Pharmacol Ther</source>. (<year>2025</year>) <volume>41</volume>(<issue>6</issue>):<fpage>347</fpage>&#x2013;<lpage>54</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/jop.2024.0210</pub-id>, PMID: <pub-id pub-id-type="pmid">40322907</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sai Varsha</surname> <given-names>MK</given-names></name>
<name><surname>Raman</surname> <given-names>T</given-names></name>
<name><surname>Manikandan</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis</article-title>. <source>Exp Eye Res</source>. (<year>2014</year>) <volume>128</volume>:<fpage>73</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exer.2014.09.007</pub-id>, PMID: <pub-id pub-id-type="pmid">25257692</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/196066">Chiara Bianca Maria Platania</ext-link>, University of Catania, Italy</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1710102">Palaiologos Alexopoulos</ext-link>, New York University, United States; <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3159891">Misbah Hanif</ext-link>, Dow University of Health Sciences, Pakistan</p></fn>
</fn-group>
</back>
</article>